Similarly, a 2022 meta-analysis by McFarland et al. found that among cancer patients, those with higher peripheral IL-6 and TNF-α levels had significantly worse depression scores (pooled effect sizes ~0.6–0.7). Here, IL6 is linked to depressive disorder.